Literature DB >> 1965528

Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle.

C Guarnieri1, C Muscari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1965528     DOI： 10.1007/bf00051282

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  7 in total

1.  Oxidative phosphorylation and respiration by mitochondria from normal, hypertrophied and failing rat hearts.

Authors:  T J Raczniak; C F Chesney; J R Allen
Journal:  J Mol Cell Cardiol       Date:  1977-03       Impact factor: 5.000

Review 2.  Subcellular basis of cardiac contractile failure.

Authors:  N S Dhalla; P K Das; G P Sharma
Journal:  J Mol Cell Cardiol       Date:  1978-04       Impact factor: 5.000

3.  Oxygen radicals and tissue damage in heart hypertrophy.

Authors:  C Guarnieri; C Muscari; C M Caldarera
Journal:  Adv Myocardiol       Date:  1985

4.  Temperature effects on the kinetics of calcium transport by cardiac mitochondria.

Authors:  A J Williams; S E Barrie
Journal:  Biochem Biophys Res Commun       Date:  1978-09-14       Impact factor: 3.575

5.  Prolonged activation of rat lung ornithine decarboxylase in monocrotaline-induced pulmonary hypertension.

Authors:  J W Olson; R J Altiere; M N Gillespie
Journal:  Biochem Pharmacol       Date:  1984-11-15       Impact factor: 5.858

6.  Lipid peroxidation of skeletal muscle: an in vitro study.

Authors:  M J Jackson; D A Jones; R H Edwards
Journal:  Biosci Rep       Date:  1983-07       Impact factor: 3.840

7.  Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats.

Authors:  T Sugita; T M Hyers; I M Dauber; W W Wagner; I F McMurtry; J T Reeves
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-02
  7 in total
  10 in total

Review 1.  The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.

Authors:  John J Ryan; Stephen L Archer
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 2.  Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.

Authors:  K J McClellan; G L Plosker
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

3.  Anticonvulsant and antioxidant actions of trimetazidine in pentylenetetrazole-induced kindling model in mice.

Authors:  Seema Jain; Nidhi Bharal; Sonam Khurana; Pramod Kumari Mediratta; Krishna Kishore Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-12       Impact factor: 3.000

Review 4.  Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension.

Authors:  John J Ryan; Stephen L Archer
Journal:  Circulation       Date:  2015-05-12       Impact factor: 29.690

5.  Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.

Authors:  Yong-Hu Fang; Lin Piao; Zhigang Hong; Peter T Toth; Glenn Marsboom; Peter Bache-Wiig; Jalees Rehman; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2011-08-28       Impact factor: 4.599

6.  Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group.

Authors:  J M Detry; P Sellier; S Pennaforte; D Cokkinos; H Dargie; P Mathes
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

7.  Protective Role of Trimetazidine Against Neomycin-induced Hair Cell Damage in Zebrafish.

Authors:  Jiwon Chang; Gi Jung Im; Sung Won Chae; Seung Hoon Lee; Soon-Young Kwon; Hak Hyun Jung; Ah-Young Chung; Hae-Chul Park; June Choi
Journal:  Clin Exp Otorhinolaryngol       Date:  2013-11-29       Impact factor: 3.372

8.  Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.

Authors:  Lili Wu; Yi Luan; Ya Li; Min Wang; Jialin He; Chongying Jin; Wenbin Zhang
Journal:  BMC Cardiovasc Disord       Date:  2020-06-05       Impact factor: 2.298

9.  Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension.

Authors:  Stephen L Archer; Yong-Hu Fang; John J Ryan; Lin Piao
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

10.  Trimedazidine alleviates pulmonary artery banding-induced acute right heart dysfunction and activates PRAS40 in rats.

Authors:  Yunshan Cao; Jiyang Song; Shutong Shen; Heling Fu; Xiang Li; Ying Xu; Aqian Wang; Xinli Li; Min Zhang
Journal:  Oncotarget       Date:  2017-09-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.